Asthma prophylaxis must be taken over a period of time to be effective. These drugs, however, are not suitable for the onset of the disease.
The global Asthma Preventive market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Asthma Preventive, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Asthma Preventive, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Asthma Preventive, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Asthma Preventive sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Asthma Preventive market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Asthma Preventive sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Novartis
Roche
GSK
Merck
Astrazeneca
Biotest AG
Boehringer Ingelheim
Chiesi
Sumitomo Dainippon Pharma
Amgen
Segment by Type
Sodium Cromolyn
Prednisolone
Segment by Application
Children
Adult
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Asthma Preventive in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Asthma Preventive manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Asthma Preventive sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Asthma Preventive Product Introduction
1.2 Market by Type
1.2.1 Global Asthma Preventive Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Sodium Cromolyn
1.2.3 Prednisolone
1.3 Market by Application
1.3.1 Global Asthma Preventive Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Asthma Preventive Sales Estimates and Forecasts 2019-2030
2.2 Global Asthma Preventive Revenue by Region
2.2.1 Global Asthma Preventive Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Asthma Preventive Revenue by Region (2019-2024)
2.2.3 Global Asthma Preventive Revenue by Region (2025-2030)
2.2.4 Global Asthma Preventive Revenue Market Share by Region (2019-2030)
2.3 Global Asthma Preventive Sales Estimates and Forecasts 2019-2030
2.4 Global Asthma Preventive Sales by Region
2.4.1 Global Asthma Preventive Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Asthma Preventive Sales by Region (2019-2024)
2.4.3 Global Asthma Preventive Sales by Region (2025-2030)
2.4.4 Global Asthma Preventive Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Asthma Preventive Sales by Manufacturers
3.1.1 Global Asthma Preventive Sales by Manufacturers (2019-2024)
3.1.2 Global Asthma Preventive Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Asthma Preventive in 2023
3.2 Global Asthma Preventive Revenue by Manufacturers
3.2.1 Global Asthma Preventive Revenue by Manufacturers (2019-2024)
3.2.2 Global Asthma Preventive Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Asthma Preventive Revenue in 2023
3.3 Global Key Players of Asthma Preventive, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Asthma Preventive Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Asthma Preventive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Asthma Preventive, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Asthma Preventive, Product Offered and Application
3.8 Global Key Manufacturers of Asthma Preventive, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Asthma Preventive Sales by Type
4.1.1 Global Asthma Preventive Historical Sales by Type (2019-2024)
4.1.2 Global Asthma Preventive Forecasted Sales by Type (2025-2030)
4.1.3 Global Asthma Preventive Sales Market Share by Type (2019-2030)
4.2 Global Asthma Preventive Revenue by Type
4.2.1 Global Asthma Preventive Historical Revenue by Type (2019-2024)
4.2.2 Global Asthma Preventive Forecasted Revenue by Type (2025-2030)
4.2.3 Global Asthma Preventive Revenue Market Share by Type (2019-2030)
4.3 Global Asthma Preventive Price by Type
4.3.1 Global Asthma Preventive Price by Type (2019-2024)
4.3.2 Global Asthma Preventive Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Asthma Preventive Sales by Application
5.1.1 Global Asthma Preventive Historical Sales by Application (2019-2024)
5.1.2 Global Asthma Preventive Forecasted Sales by Application (2025-2030)
5.1.3 Global Asthma Preventive Sales Market Share by Application (2019-2030)
5.2 Global Asthma Preventive Revenue by Application
5.2.1 Global Asthma Preventive Historical Revenue by Application (2019-2024)
5.2.2 Global Asthma Preventive Forecasted Revenue by Application (2025-2030)
5.2.3 Global Asthma Preventive Revenue Market Share by Application (2019-2030)
5.3 Global Asthma Preventive Price by Application
5.3.1 Global Asthma Preventive Price by Application (2019-2024)
5.3.2 Global Asthma Preventive Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Asthma Preventive Market Size by Type
6.1.1 US & Canada Asthma Preventive Sales by Type (2019-2030)
6.1.2 US & Canada Asthma Preventive Revenue by Type (2019-2030)
6.2 US & Canada Asthma Preventive Market Size by Application
6.2.1 US & Canada Asthma Preventive Sales by Application (2019-2030)
6.2.2 US & Canada Asthma Preventive Revenue by Application (2019-2030)
6.3 US & Canada Asthma Preventive Market Size by Country
6.3.1 US & Canada Asthma Preventive Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Asthma Preventive Sales by Country (2019-2030)
6.3.3 US & Canada Asthma Preventive Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Asthma Preventive Market Size by Type
7.1.1 Europe Asthma Preventive Sales by Type (2019-2030)
7.1.2 Europe Asthma Preventive Revenue by Type (2019-2030)
7.2 Europe Asthma Preventive Market Size by Application
7.2.1 Europe Asthma Preventive Sales by Application (2019-2030)
7.2.2 Europe Asthma Preventive Revenue by Application (2019-2030)
7.3 Europe Asthma Preventive Market Size by Country
7.3.1 Europe Asthma Preventive Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Asthma Preventive Sales by Country (2019-2030)
7.3.3 Europe Asthma Preventive Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Asthma Preventive Market Size
8.1.1 China Asthma Preventive Sales (2019-2030)
8.1.2 China Asthma Preventive Revenue (2019-2030)
8.2 China Asthma Preventive Market Size by Application
8.2.1 China Asthma Preventive Sales by Application (2019-2030)
8.2.2 China Asthma Preventive Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Asthma Preventive Market Size by Type
9.1.1 Asia Asthma Preventive Sales by Type (2019-2030)
9.1.2 Asia Asthma Preventive Revenue by Type (2019-2030)
9.2 Asia Asthma Preventive Market Size by Application
9.2.1 Asia Asthma Preventive Sales by Application (2019-2030)
9.2.2 Asia Asthma Preventive Revenue by Application (2019-2030)
9.3 Asia Asthma Preventive Sales by Region
9.3.1 Asia Asthma Preventive Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Asthma Preventive Revenue by Region (2019-2030)
9.3.3 Asia Asthma Preventive Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Asthma Preventive Market Size by Type
10.1.1 Middle East, Africa and Latin America Asthma Preventive Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Asthma Preventive Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Asthma Preventive Market Size by Application
10.2.1 Middle East, Africa and Latin America Asthma Preventive Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Asthma Preventive Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Asthma Preventive Sales by Country
10.3.1 Middle East, Africa and Latin America Asthma Preventive Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Asthma Preventive Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Asthma Preventive Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Pfizer Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Abbot
11.2.1 Abbot Company Information
11.2.2 Abbot Overview
11.2.3 Abbot Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Abbot Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbot Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Novartis Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Overview
11.4.3 Roche Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Roche Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Recent Developments
11.5 GSK
11.5.1 GSK Company Information
11.5.2 GSK Overview
11.5.3 GSK Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 GSK Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GSK Recent Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Overview
11.6.3 Merck Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Merck Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck Recent Developments
11.7 Astrazeneca
11.7.1 Astrazeneca Company Information
11.7.2 Astrazeneca Overview
11.7.3 Astrazeneca Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Astrazeneca Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Astrazeneca Recent Developments
11.8 Biotest AG
11.8.1 Biotest AG Company Information
11.8.2 Biotest AG Overview
11.8.3 Biotest AG Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Biotest AG Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biotest AG Recent Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Information
11.9.2 Boehringer Ingelheim Overview
11.9.3 Boehringer Ingelheim Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Boehringer Ingelheim Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Boehringer Ingelheim Recent Developments
11.10 Chiesi
11.10.1 Chiesi Company Information
11.10.2 Chiesi Overview
11.10.3 Chiesi Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Chiesi Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Chiesi Recent Developments
11.11 Sumitomo Dainippon Pharma
11.11.1 Sumitomo Dainippon Pharma Company Information
11.11.2 Sumitomo Dainippon Pharma Overview
11.11.3 Sumitomo Dainippon Pharma Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Sumitomo Dainippon Pharma Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sumitomo Dainippon Pharma Recent Developments
11.12 Amgen
11.12.1 Amgen Company Information
11.12.2 Amgen Overview
11.12.3 Amgen Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Amgen Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Amgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Asthma Preventive Industry Chain Analysis
12.2 Asthma Preventive Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Asthma Preventive Production Mode & Process
12.4 Asthma Preventive Sales and Marketing
12.4.1 Asthma Preventive Sales Channels
12.4.2 Asthma Preventive Distributors
12.5 Asthma Preventive Customers
13 Market Dynamics
13.1 Asthma Preventive Industry Trends
13.2 Asthma Preventive Market Drivers
13.3 Asthma Preventive Market Challenges
13.4 Asthma Preventive Market Restraints
14 Key Findings in The Global Asthma Preventive Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Pfizer
Abbot
Novartis
Roche
GSK
Merck
Astrazeneca
Biotest AG
Boehringer Ingelheim
Chiesi
Sumitomo Dainippon Pharma
Amgen
听
听
*If Applicable.